Skip to main content

Table 1 Demographics and baseline characteristics (safety population)

From: Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium

Characteristics

Patients (N = 167)

Age (years), mean (SD)

64.5 (7.92)

Sex, n (%)

 

Male

128 (76.6)

Female

39 (23.4)

Race, n (%)

 

Caucasian

165 (98.8)

Others

2 (1.2)

BMI (kg/m2), mean (SD)

26.8 (4.71)

Duration of COPD (years), mean (SD)

9.1 (7.91)

Smoking history, n (%)

 

Ex-smoker

95 (56.9)

Current smoker

72 (43.1)

Number of pack-years, mean (SD)

43.1 (19.62)

Post-bronchodilator FEV1 (% predicted), mean (SD)

56.7 (13.58)

Post-bronchodilator FEV1/FVC (%), mean (SD)

50.1 (10.04)

FEV1 reversibility (% increase), mean (SD)

14.3 (12.26)

  1. SD = standard deviation; BMI = body mass index; FEV1 = forced expiratory volume in 1s; FVC = forced vital capacity; pack-years = total years of smoking multiplied by cigarette packs smoked per day.